Target intelligence / Profile preview

UBE2Q1 antisense RNA 1 (UBE2Q1-AS1)

Target
UBE2Q1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

UBE2Q1 antisense RNA 1 (UBE2Q1-AS1) is a long non-coding RNA transcribed in the antisense orientation relative to the UBE2Q1 gene. As a member of the antisense RNA class, it is presumed to act primarily as a regulator of gene expression, potentially affecting the expression, processing, or stability of the UBE2Q1 sense transcript or other related genes. Antisense RNAs such as UBE2Q1-AS1 can modulate transcription and epigenetic states, participate in chromatin remodeling, or influence mRNA splicing and stability, with dysregulation linked to diseases including various cancers[2][3]. UBE2Q1-AS1 itself is not a protein-coding gene nor considered a canonical therapeutic target such as a receptor or enzyme, though interest in non-coding RNAs as drug targets is increasing due to their implications in gene regulation and disease[2][3].

Other names
UBE2Q1 antisense RNA 1 (non-protein coding)UBE2Q1-AS1
02

Mechanism of action

Not applicable (UBE2Q1-AS1 is not a direct target for current drugs, but antisense RNA may be modulated by antisense oligonucleotide therapeutics in general[2])

03

Biological functions

Regulation of gene expressionEpigenetic regulationModulation of transcription
04

Disease associations

CancerOther (potential roles inferred by antisense RNA class, as seen in various disorders[2])

Beyond the preview

Go deeper on UBE2Q1 antisense RNA 1 (UBE2Q1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2Q1 antisense RNA 1 (UBE2Q1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call